Prognostic significance of positive margin-informed tumor status in esophageal squamous cell carcinoma using next-generation sequencing
The Oncologist · 2026
DOI: 10.1093/oncolo/oyag337 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Di Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, High-Throughput Nucleotide Sequencing, Esophageal Neoplasms, Tumor Suppressor Protein p53. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Project of Guangdong Province, Young Scientists Fund of the National Natural Science Foundation of China, General Program of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Reliable prognostic biomarkers are urgently needed for operable esophageal squamous cell carcinoma (ESCC), as conventional histopathology often fails to detect minimal residual disease and accurately predict patient outcomes. Patients and Methods This study investigated the mutational patterns in ESCC and the prognostic value of shared mutations between tumors and margins (margin-informed tumor, MiT) using next-generation sequencing. We analyzed tumor, margin, and normal tissues from a total of 70 patients with operable ESCC, including 48 from a retrospective cohort and 22 from a prospective cohort.
Results
TP53 mutations were more prevalent in tumors than in margins or normal tissues (retrospective, P <.0001; prospective, P = .02), while NOTCH1 mutations were more frequent in normal or margin tissues (retrospective, P = .0002; prospective, P = .07). Positive MiT was observed in 16.7% of the retrospective cohort and 45.5% of the prospective cohort, respectively, with all patients exhibiting over 50% shared mutations experiencing disease progression. Patients with identical TP53 mutations in both tumor and margin tissues (TP53-MiT) exhibited significantly worse survival (retrospective, hazard ratio [HR] = 3.32, 95% confidence interval [CI], 1.11-9.91, P = .03; prospective, HR = 4.35, 95% CI, 0.87-21.63, P = .05). TP53 mutations were associated with tumorigenic pathways and low immune infiltration fraction.
Conclusion
Our findings underscore the clinical importance of MiT, particularly TP53-MiT, in postoperative prognosis. Integrating TP53-MiT assessment into postoperative evaluations could refine risk stratification and guide adjuvant management better.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
- Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu 210032, China.
ORCID-Profile: Di Lu, Yu Tong, Chunhong He, Zhiming Chen, Zhizhi Wang, Jingwen Liu, Jiani C Yin, Shaobin Li, Shijie Mai, Xuguang Rao, Kaican Cai
Förderung
- Science and Technology Planning Project of Guangdong Province
- Young Scientists Fund of the National Natural Science Foundation of China
- General Program of the National Natural Science Foundation of China
- Major Scientific Research Issues and Medical Technology Challenges of the China Medicine Education Association
Zitieren
APA
Lu, D., Tong, Y., He, C., Chen, Z., Wang, Z., Liu, J., Yin, J. C., Li, S., Mai, S., Rao, X., & Cai, K. (2026). Prognostic significance of positive margin-informed tumor status in esophageal squamous cell carcinoma using next-generation sequencing. The Oncologist. https://doi.org/10.1093/oncolo/oyag337
Vancouver
Lu D, Tong Y, He C, Chen Z, Wang Z, Liu J, et al. Prognostic significance of positive margin-informed tumor status in esophageal squamous cell carcinoma using next-generation sequencing. The Oncologist. 2026. doi:10.1093/oncolo/oyag337
BibTeX
@article{Lu2026,
author = {Lu, Di and Tong, Yu and He, Chunhong and Chen, Zhiming and Wang, Zhizhi and Liu, Jingwen and Yin, Jiani C and Li, Shaobin and Mai, Shijie and Rao, Xuguang and Cai, Kaican},
title = {Prognostic significance of positive margin-informed tumor status in esophageal squamous cell carcinoma using next-generation sequencing},
journal = {The Oncologist},
year = {2026},
doi = {10.1093/oncolo/oyag337}
}
EUVIMED